Literature DB >> 20431617

Aqabamycins A-G: novel nitro maleimides from a marine Vibrio species. I. Taxonomy, fermentation, isolation and biological activities.

Wael Al-Zereini1, Clarisse Blanchine Fotso Fondja Yao, Hartmut Laatsch, Heidrun Anke.   

Abstract

In a screening of marine bacteria, a Vibrio species isolated from the surface of the soft coral Sinularia polydactyla collected in the Red Sea was found to be a prolific producer of secondary metabolites with antibacterial and cytotoxic activities. Seven novel maleimide derivatives named aqabamycin A (1a), aqabamycin B (1b), aqabamycin C (1c), aqabamycin D (1d), aqabamycin E (1e and 1e'), aqabamycin F (1f) and aqabamycin G (2) were isolated together with several known metabolites such as 3-nitro-1H-indazole (3), indazole-3-carbaldehyde (4), phenyl-2-bis-indolylmethane (5a), turbomycin B (5b), vibrindole A (6), 1,4-dithiane (7), 3-(3-nitro-4-hydroxyphenyl)-2-propenoic acid (8), 3-nitro-4-hydroxybenzaldehyde (9), phenylacetic acid, benzoic acid, 3-hydroxybenzoic acid and 4-hydroxycinnamic acid. The aqabamycins, except aqabamycin A, bear a nitro group. Compounds 3, 4, 7 are described here for the first time from a natural source and vibrindole A was found to have cytotoxic activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20431617     DOI: 10.1038/ja.2010.34

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  10 in total

Review 1.  Production of bioactive secondary metabolites by marine vibrionaceae.

Authors:  Maria Mansson; Lone Gram; Thomas O Larsen
Journal:  Mar Drugs       Date:  2011-08-25       Impact factor: 6.085

Review 2.  Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2013-07-16       Impact factor: 5.118

Review 3.  Marine microorganism-invertebrate assemblages: perspectives to solve the "supply problem" in the initial steps of drug discovery.

Authors:  Miguel Costa Leal; Christopher Sheridan; Ronald Osinga; Gisela Dionísio; Rui Jorge Miranda Rocha; Bruna Silva; Rui Rosa; Ricardo Calado
Journal:  Mar Drugs       Date:  2014-06-30       Impact factor: 5.118

4.  Antimicrobial activity of bacteria isolated from Red Sea marine invertebrates.

Authors:  Manar El Samak; Samar M Solyman; Amro Hanora
Journal:  Biotechnol Rep (Amst)       Date:  2018-07-20

5.  Anti-Leishmanial and Cytotoxic Activities of a Series of Maleimides: Synthesis, Biological Evaluation and Structure-Activity Relationship.

Authors:  Yongxian Fan; Yuele Lu; Xiaolong Chen; Babu Tekwani; Xing-Cong Li; Yinchu Shen
Journal:  Molecules       Date:  2018-11-05       Impact factor: 4.411

Review 6.  Bioactive Secondary Metabolites from Octocoral-Associated Microbes-New Chances for Blue Growth.

Authors:  Inês Raimundo; Sandra G Silva; Rodrigo Costa; Tina Keller-Costa
Journal:  Mar Drugs       Date:  2018-12-04       Impact factor: 5.118

7.  Isolation and Antibacterial Activity of Indole Alkaloids from Pseudomonas aeruginosa UWI-1.

Authors:  Antonio Ramkissoon; Mohindra Seepersaud; Anderson Maxwell; Jayaraj Jayaraman; Adesh Ramsubhag
Journal:  Molecules       Date:  2020-08-17       Impact factor: 4.411

8.  Streptomyces sp. 1S1 isolated from Southern coast of the Red Sea as a renewable natural resource of several bioactive compounds.

Authors:  Azal A Mothana; Hassan A Al-Shamahy; Ramzi A Mothana; Jamal M Khaled; Adnan J Al-Rehaily; Abdullah Y Al-Mahdi; Ulrike Lindequist
Journal:  Saudi Pharm J       Date:  2021-12-31       Impact factor: 4.562

Review 9.  Marine Indole Alkaloids.

Authors:  Natalie Netz; Till Opatz
Journal:  Mar Drugs       Date:  2015-08-06       Impact factor: 5.118

10.  Thalassospiramide G, a new γ-amino-acid-bearing peptide from the marine bacterium Thalassospira sp.

Authors:  Soohyun Um; Yuna Pyee; Eun-Hee Kim; Sang Kook Lee; Jongheon Shin; Dong-Chan Oh
Journal:  Mar Drugs       Date:  2013-02-26       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.